-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) and ulcerative colitis (UC) are immune- mediated intestinal diseases, and together they constitute inflammatory bowel disease (IBD)
Crohn's disease (CD) and ulcerative colitis (UC) are immune- mediated intestinal diseases, and together they constitute inflammatory bowel disease (IBD)
Recently, data suggests that adverse outcomes, especially in elderly patients, may be caused by weakness rather than chronological age
Researchers used the National Readmission Database to examine the clinical data of all IBD patients hospitalized across the United States from 2010 to 2014
diagnosis
The results of the study showed that from 2010 to 2014, a total of 1,405,529 IBD admissions were identified, of which 152,974 (10.
This study confirms that weakness that is not related to age, comorbidities, and severity of admission is associated with a higher risk of re-admission and death in IBD patients, and that the prevalence is increasing
This study confirms that weakness that is not related to age, comorbidities, and severity of admission is associated with a higher risk of re-admission and death in IBD patients, and that the prevalence is increasing
Adam S.
Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.
Leave a message here
